107 related articles for article (PubMed ID: 6323515)
1. Blocking 3-hydroxy-3-methylglutaryl coenzyme A reductase with ML-236B enhances the plasma cortisol response to adrenocorticotropin in patients with hypercholesterolemia.
Yamaguchi K; Nakamura N; Uzawa H
J Clin Endocrinol Metab; 1984 May; 58(5):786-9. PubMed ID: 6323515
[TBL] [Abstract][Full Text] [Related]
2. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
3. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
N Engl J Med; 1981 Aug; 305(9):478-82. PubMed ID: 7254297
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of ML-236B in primary hypercholesterolemia.
Yamamoto A; Sudo H; Endo A
Atherosclerosis; 1980 Mar; 35(3):259-66. PubMed ID: 7362699
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
Dobs AS; Schrott H; Davidson MH; Bays H; Stein EA; Kush D; Wu M; Mitchel Y; Illingworth RD
Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911
[TBL] [Abstract][Full Text] [Related]
6. The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects.
Nakaya N; Homma Y; Tamachi H; Shigematsu H; Hata Y; Goto Y
JAMA; 1987 Jun; 257(22):3088-93. PubMed ID: 3108527
[TBL] [Abstract][Full Text] [Related]
7. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
8. Effects of cortisol or corticotropin administration on hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity and plasma lipids in the pregnant rat and fetuses.
Innis SM; Haave NC
J Dev Physiol; 1989 Jun; 11(6):346-50. PubMed ID: 2556470
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II.
JAMA; 1986 Nov; 256(20):2829-34. PubMed ID: 3534333
[TBL] [Abstract][Full Text] [Related]
10. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
[TBL] [Abstract][Full Text] [Related]
11. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
[TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
Behrens-Baumann W; Thiery J; Wieland E; Fieseler HG; Seidel D
Arzneimittelforschung; 1992 Aug; 42(8):1023-4. PubMed ID: 1418074
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
15. [Hypercholesterolemia: therapeutic approach].
Alessandri C; Peverini F
Clin Ter; 1991 Jun; 137(6):373-97. PubMed ID: 1832610
[TBL] [Abstract][Full Text] [Related]
16. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
[TBL] [Abstract][Full Text] [Related]
17. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway.
Laue L; Hoeg JM; Barnes K; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1987 Mar; 64(3):531-5. PubMed ID: 3029155
[TBL] [Abstract][Full Text] [Related]
18. Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads.
Travia D; Tosi F; Negri C; Faccini G; Moghetti P; Muggeo M
J Clin Endocrinol Metab; 1995 Mar; 80(3):836-40. PubMed ID: 7883839
[TBL] [Abstract][Full Text] [Related]
19. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
